
The Model for End-stage Liver Disease (MELD) score is the basis for allocation of liver allografts for transplantation in the United States. The MELD score, as an objective scale of disease severity, is also used in the management of patients with chronic liver disease in the nontransplant setting. Several models have been proposed to improve the MELD score. The authors believe that the MELD score is, by design, continually evolving and lends itself to continued refinement and improvement to serve as a metric to optimize organ allocation in the future.
Male, Reoperation, Waiting Lists, Patient Selection, Sodium, Bilirubin, Models, Biological, Severity of Illness Index, Liver Transplantation, End Stage Liver Disease, Sex Factors, Treatment Outcome, Creatinine, Humans, Female, International Normalized Ratio, Biomarkers
Male, Reoperation, Waiting Lists, Patient Selection, Sodium, Bilirubin, Models, Biological, Severity of Illness Index, Liver Transplantation, End Stage Liver Disease, Sex Factors, Treatment Outcome, Creatinine, Humans, Female, International Normalized Ratio, Biomarkers
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 54 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
